Issues related to medication use?
Hello Director Liu: My uncle is a terminal prostate cancer patient with metastases to the ischium, femur, and lymph nodes.
The doctor has prescribed "Androcur" to manage his condition.
I would like to ask you, Director Liu: "What is the typical duration of effectiveness for 'Androcur'? Is it clinically possible to control the cancer for 3 years, 5 years, or even coexist with the cancer?" I look forward to your response and greatly appreciate it.
Qiu zhu, 30~39 year old female. Ask Date: 2009/12/27
Dr. Liu Jianting reply Urology
The medication used is effective in controlling the condition, but the duration of its effectiveness will depend on the extent and progression of the disease.
Of course, if the results are not satisfactory, there are other medications that can be added for enhancement.
Please closely cooperate with the physician responsible for your uncle's care.
Reply Date: 2009/12/27
More Info
Androcur, known generically as cyproterone acetate, is an anti-androgen medication that is often used in the treatment of prostate cancer, particularly in cases where the cancer has advanced and metastasized. It works by blocking the effects of testosterone, which can fuel the growth of prostate cancer cells. In your uncle's case, where he is dealing with advanced prostate cancer that has metastasized to the bones and lymph nodes, the use of Androcur is a common therapeutic approach.
The effectiveness of Androcur can vary significantly from patient to patient. Generally, the duration of effectiveness for Androcur in controlling prostate cancer is typically around 6 months to 2 years. This is largely dependent on the individual’s response to the medication, the extent of the disease, and other factors such as overall health and concurrent treatments. In some cases, patients may experience a longer duration of control, but it is less common for Androcur to provide effective control for 3 to 5 years, especially in advanced stages of cancer.
Clinical studies have shown that while Androcur can effectively manage symptoms and slow the progression of prostate cancer, it is not a curative treatment. The cancer may eventually become resistant to hormonal therapies, including Androcur, leading to disease progression. This phenomenon is known as castration-resistant prostate cancer (CRPC), where the cancer continues to grow despite low levels of testosterone.
In terms of long-term management, some patients may achieve a state of "living with cancer" where the disease is controlled for extended periods, but this is often through a combination of therapies rather than relying solely on Androcur. Other treatments, such as newer hormonal agents (e.g., enzalutamide, abiraterone) or chemotherapy, may be introduced as the disease progresses or if Androcur becomes less effective.
It is also important to consider the side effects associated with Androcur, which can include fatigue, weight gain, mood changes, and sexual dysfunction. These side effects can impact the quality of life, and managing them is an essential part of treatment.
In summary, while Androcur can be an effective part of the treatment regimen for advanced prostate cancer, its effectiveness is generally limited to a shorter duration, and achieving long-term control (3 to 5 years) is less common. Continuous monitoring and open communication with healthcare providers are crucial for adjusting treatment plans as needed and exploring additional therapeutic options if necessary. Your uncle's healthcare team will be best positioned to provide personalized insights based on his specific situation and response to treatment.
Similar Q&A
Understanding Androcur: Efficacy and Long-Term Use in Prostate Cancer
Dear Dr. Fan, I am unsure whether to direct my question to the Hematology-Oncology department or Urology. My inquiry is as follows: My uncle is a terminal prostate cancer patient with metastases to the pelvis, femur, and lymph nodes. The initial hormone therapy he received had s...
Dr. Fan Sheng reply Oncology
Hello: You mentioned that your uncle is a terminal prostate cancer patient, and he should have undergone either orchiectomy or received subcutaneous injections of androgen deprivation therapy. Generally, this approach can be effective for about one and a half to two years. After ...[Read More] Understanding Androcur: Efficacy and Long-Term Use in Prostate Cancer
Understanding Second-Line Hormonal Treatments for Advanced Prostate Cancer
Dear Director Hsu, I admire your dedication in responding to inquiries from netizens amidst your busy schedule at Taiwan e-Hospital. My father-in-law is a terminal prostate cancer patient who has been undergoing hormone injection therapy for over two years. Recently, his PSA lev...
Dr. Xu Weikai reply Urology
Jasmine: Hello, I personally do not have much experience with second-line hormone therapy, and I cannot provide you with extensive information. It may be more appropriate to consult directly with your attending physician for detailed advice. Additionally, if the treatment is inef...[Read More] Understanding Second-Line Hormonal Treatments for Advanced Prostate Cancer
Combining Radium-223 with Second-Line Hormonal Therapy: Key Considerations
Hello, I have stage IV prostate cancer with bone metastasis and have developed bone pain. My PSA level has exceeded 100, and I am currently awaiting Radium-223 treatment. I would like to inquire about the use of enzalutamide to suppress the rate of PSA increase. If I continue to ...
Dr. Jian Weihong reply Urology
Hello: Based on my understanding, Radium-223 (such as Xofigo) is to be used under specific conditions and cannot be combined with enzalutamide. It is indicated for the treatment of castration-resistant prostate cancer (CRPC) patients who have symptomatic bone metastases and no vi...[Read More] Combining Radium-223 with Second-Line Hormonal Therapy: Key Considerations
Essential Health Checks While Taking Boska: What to Focus On?
I have been taking Bicalutamide for a year, following the doctor's recommended dosage: one pill cut into four pieces, taking one piece daily. I have not experienced any physical discomfort, and I have been regularly visiting a dermatologist. However, I still have concerns an...
Dr. Xiao Yongxun reply Family Medicine
Dear Mr. K: 1. PROSCAR® (finasteride) is a specific inhibitor of Type II 5α-reductase. Type II 5α-reductase is an intracellular enzyme that metabolizes testosterone into a more potent androgen: dihydrotestosterone (DHT). The phenomenon of benign prostatic hyperplasia (BPH) is in...[Read More] Essential Health Checks While Taking Boska: What to Focus On?
Related FAQ
(Urology)
Sildenafil(Urology)
Bph(Urology)
Nocturia(Urology)
Hematospermia(Urology)
Testosterone(Urology)
Semen Analysis(Urology)
Post-Prostate Surgery(Urology)
Vasectomy(Urology)
Prostate-Specific Antigen(Urology)